Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Jeremy M. Levin | CEO | 2024-03-18 | 18,248 | $2.76 | $50.36kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Takeda Pharmaceutical Co Ltd | 10.65% | 7,531,996 | $23.05M | Insider |
Bvf Inc | 9.69% | 6,851,051 | $20.96M | Institution |
Ecor1 Capital LLC | 8.65% | 6,117,400 | $18.72M | Institution |
Rubric Capital Management LP | 7.52% | 5,315,969 | $16.27M | Institution |
Matthew During | 6.75% | 4,772,429 | $14.60M | Insider |
Blackrock Inc | 6.11% | 4,319,918 | $13.22M | Institution |
Jeremy M. Levin | 5.17% | 3,652,176 | $11.18M | Insider |
Madison Avenue Partners LP | 5.16% | 3,648,509 | $11.16M | Institution |
Vanguard Group Inc | 4.23% | 2,989,777 | $9.15M | Institution |
Artal Group Sa | 3.54% | 2,500,000 | $7.65M | Institution |